Sign in

NCT07168616Recruiting

Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance

Prospective Evaluation of Istanbul PSMA PET/CT Criteria for Selecting Candidates for Active Surveillance in Low-Risk Prostate Cancer

Source: ClinicalTrials.gov · Last updated 15 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a multicenter, prospective diagnostic accuracy study evaluating the Istanbul PSMA PET/CT Criteria (IPPC) for selecting patients with biopsy-confirmed low-risk prostate cancer (ISUP Grade 1) for active surveillance (AS). The study integrates delayed Ga-68 PSMA PET/CT imaging into the diagnostic pathway to refine patient stratification, minimize overtreatment and potentially reduce unnecessary biopsies and MRI, or exposing high-risk individuals to the danger of cancer progression if left untreated scans.

Status (registry)
Recruiting
Study type
Observational
Enrollment
201 (estimated)
First submitted
5 Sept 2025
Start date
1 Sept 2025
Primary completion date
15 Sept 2026
Lead sponsor
Istanbul University - Cerrahpasa
NCT number
NCT07168616

What you commit to

  • Study type: Observational
  • Planned participants: 201
  • From 1 Sept 2025 to the primary completion date, 15 Sept 2026
  • 10 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior prostate cancer treatment or prostate surgery

Other illness

  • History of pelvic radiotherapy
  • Severe renal impairment

Age

  • Life expectancy \<10 years

Other

  • High-risk or unfavorable intermediate-risk PCa, or adverse histologies (neuroendocrine, ductal adenocarcinoma, basal cell carcinoma, TP53 or BRCA1/2 mutations if available)
  • MRI evidence of extracapsular extension, seminal vesicle invasion, or nodal metastasis
  • Inability to comply with follow-up schedule

Who the study is looking for

  • mpMRI performed within 3 months prior to enrollment
  • Systematic or MRI-targeted prostate biopsy performed
  • Biopsy-confirmed ISUP Grade 1 low-risk PCa
  • Prostate biopsy report specifying tumor localization and number of positive cores
  • Meets AS criteria: ISUP 1, PSA ≤10 ng/mL, PSAd \>0.15 ng/mL², clinical stage cT1c-T2a, ≤3 positive cores
  • Life expectancy ≥10 years
  • No prior PSMA PET imaging
  • No evidence of extra-prostatic disease on mpMRI
  • Signed informed consent for study procedures

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (10)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Bilkent Şehir Hastanesi
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Recruiting
Gazi Yaşargil Egitim ve Arastirma Hastanesi
Coordinator of this site? Confirm its status
DiyarbakırTurkey (Türkiye)Recruiting
Gaziantep Üniversitesi Şahinbey Araştırma ve Uygulama hastanesi
Coordinator of this site? Confirm its status
GaziantepTurkey (Türkiye)Recruiting
Acibadem University Altunizade Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting
İstanbul University-Cerrahpaşa
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting
Acibadem University Maslak Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting
Sisli Hamidiye Etfal Eğitim ve Arastırma Hastanesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting
Haseki Eğitim ve Araştırma Hastanesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting
Yeditepe University
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting
SBÜ Başakşehir Çam Sakura Şehir hastanesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.